Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Clinical trial NCT05051722 · RECRUITING

Trial details

NCT number: NCT05051722
Sponsor: Mayo Clinic
Status: RECRUITING
Study type: OBSERVATIONAL

Endometrial Cancer Cervical Cancer Atypical Endometrial Hyperplasia Cervical Dysplasia Adnexal Mass Ovarian Cancer

Start date: 2021-08-03
Primary completion: 2026-12-31
Enrollment: 3110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.